AU9742298A - Parasiticidal formulations - Google Patents

Parasiticidal formulations Download PDF

Info

Publication number
AU9742298A
AU9742298A AU97422/98A AU9742298A AU9742298A AU 9742298 A AU9742298 A AU 9742298A AU 97422/98 A AU97422/98 A AU 97422/98A AU 9742298 A AU9742298 A AU 9742298A AU 9742298 A AU9742298 A AU 9742298A
Authority
AU
Australia
Prior art keywords
implant
parasiticidal compound
parasiticidal
tabletting
implants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU97422/98A
Other languages
English (en)
Inventor
Hiep Huatan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720228.7A external-priority patent/GB9720228D0/en
Priority claimed from GBGB9810143.9A external-priority patent/GB9810143D0/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of AU9742298A publication Critical patent/AU9742298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
AU97422/98A 1997-09-23 1998-09-04 Parasiticidal formulations Abandoned AU9742298A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9720228 1997-09-23
GBGB9720228.7A GB9720228D0 (en) 1997-09-23 1997-09-23 Parasiticidal formulations
GB9810143 1998-05-12
GBGB9810143.9A GB9810143D0 (en) 1998-05-12 1998-05-12 Parasiticidal formulations
PCT/EP1998/005720 WO1999015166A1 (fr) 1997-09-23 1998-09-04 Formulations antiparasitaires

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2002300653A Division AU2002300653A1 (en) 1997-09-23 2002-08-20 Parasiticidal Formulations

Publications (1)

Publication Number Publication Date
AU9742298A true AU9742298A (en) 1999-04-12

Family

ID=26312302

Family Applications (1)

Application Number Title Priority Date Filing Date
AU97422/98A Abandoned AU9742298A (en) 1997-09-23 1998-09-04 Parasiticidal formulations

Country Status (13)

Country Link
EP (1) EP1014970A1 (fr)
JP (1) JP2001517622A (fr)
AP (1) AP9801350A0 (fr)
AR (1) AR013509A1 (fr)
AU (1) AU9742298A (fr)
BR (1) BR9812385A (fr)
CA (1) CA2304283A1 (fr)
GT (1) GT199800149A (fr)
MA (1) MA24655A1 (fr)
PA (1) PA8459501A1 (fr)
PE (1) PE117199A1 (fr)
TN (1) TNSN98175A1 (fr)
WO (1) WO1999015166A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
US6645192B2 (en) 1998-09-30 2003-11-11 Ivy Animal Health, Inc. Pellet implant system for immediate and delayed release of antiparasitic drug
AU1556000A (en) * 1999-11-22 2001-06-04 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
US6953586B1 (en) 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
DE10032878A1 (de) * 2000-07-06 2002-01-17 Bayer Ag Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7918863B2 (en) 2005-06-24 2011-04-05 Conceptus, Inc. Minimally invasive surgical stabilization devices and methods
WO2018226512A1 (fr) * 2017-06-06 2018-12-13 Merck Sharp & Dohme Corp. Implant à action prolongée pour le traitement de maladies infectieuses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240274A3 (fr) * 1986-04-03 1990-03-14 Merck & Co. Inc. Avermectine comme agents pour promotion de la croissance
US4847243A (en) * 1987-10-08 1989-07-11 Merck & Co., Inc. Treatment for fescue toxicosis in grazing animals
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5411737A (en) * 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device

Also Published As

Publication number Publication date
PA8459501A1 (es) 2000-05-24
GT199800149A (es) 2000-03-15
PE117199A1 (es) 1999-11-20
AR013509A1 (es) 2000-12-27
TNSN98175A1 (fr) 2005-03-15
MA24655A1 (fr) 1999-04-01
JP2001517622A (ja) 2001-10-09
WO1999015166A1 (fr) 1999-04-01
AP9801350A0 (en) 2000-03-17
BR9812385A (pt) 2000-09-12
EP1014970A1 (fr) 2000-07-05
CA2304283A1 (fr) 1999-04-01

Similar Documents

Publication Publication Date Title
EP1035835B1 (fr) Formulations injectables a action prolongee renfermant de l'huile de ricin hydrogenee
US5439924A (en) Systemic control of parasites
US6653288B1 (en) Injectable anthelmintic compositions and methods for using same
CZ300822B6 (cs) Kapalné polymerní prostredky s rízeným uvolnováním eprinomectinu
AU9742298A (en) Parasiticidal formulations
KR20120006987A (ko) 마크로시클릭 락톤 약물 전달 시스템
KR20100020003A (ko) 안정한 비수성 외용제 조성물
CA2202707C (fr) Breuvage non aqueux contenant de l'avermectine
DE69221454T2 (de) Systemisch gegen Ektoparasiten anwendbare Juvenilhormone
KR20150094643A (ko) 향상된 수용성 및 우수한 저장 안정성을 가지는 정제
US20040247634A1 (en) Treatment of parasitic disease
EP2598151B1 (fr) Compositions pour le traitement de ver du coeur
EP3609470B1 (fr) Implants pour traiter les infestations de parasites
US20050169966A1 (en) Growth promoting pharmaceutical implant
MXPA00002843A (en) Parasiticidal formulations
CN110022862B (zh) 药物制剂及其制造方法
KR20240025534A (ko) 맛우수한 수의학적 조성물
AU709310B2 (en) Non-aqueous oral-drench compositions containing avermectin compounds
AU5995999A (en) Antiparasitic formulations

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted